Shares of Solventum Corp. SOLV slid 1.36% to $73.97 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.08% to 5,667.56 and ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Solventum Corporation (SOLV – Research Report) today and set a price target of ...

Piper Sandler analyst Jason Bednar maintained a Hold rating on Solventum Corporation (SOLV – Research Report) today and set a price target of ...

Shares of NYSE:SOLV opened at $77.96 on Wednesday. The business has a 50 day moving average price of $73.65 and a 200 day moving average price of $70.55. Solventum has a twelve month low of $47.16 ...

Solventum (NYSE:SOLV – Get Free Report) had its price target boosted by research analysts at Mizuho from $70.00 to $82.00 in a research report issued to clients and investors on Monday,Benzinga ...

Solventum Corporation (NYSE:SOLV) Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Good afternoon. My name is Ellie, and I will be your conference call operator today.

Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other ...

SOLVENTUM ($SOLV) posted quarterly earnings results on Thursday, February 27th. The company reported earnings of $1.41 per share, beating estimates of $1.35 by $0.06 ...